OMER
OMEROS CORP
Latest Form 4:Sale$190KbyBorges David J. (VP, Finance & CAO) · filed Aug 25, 2026
OMEROS CORP (OMER) has 7 SEC Form 4 filings (20 transaction rows) in the rolling window, disclosed by 2 distinct insiders. Most recent filing: Aug 25, 2026.
The most active filer is VP, Finance & CAO Borges David J. with 5 filings. Insiders have net sold $655K over the trailing 6 months.
- Industry:Biotechnology
- CEO:Gregory A. Demopulos
- Employees:202
- HQ:Seattle, WA, US
- IPO:2009-10-08
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$1.4M
reported sales (SEC code S)
Unique Insiders
2
in the rolling window
Market Cap
$1.4B
latest known value
| Source | ||||||
|---|---|---|---|---|---|---|
| VP, Finance & CAO | Sale | 10,000 | $190K | Aug 25 | SEC ↗ | |
| VP, Finance & CAO | Sale | 906 | $17K | Aug 25 | SEC ↗ | |
| Director | Sale | 15,000 | $277K | Aug 21 | SEC ↗ | |
Borges David J.First in 7 months | VP, Finance & CAO | Sale | 5,000 | $85K | Aug 17 | SEC ↗ |
Cable Thomas J.First filing | Director | Sale | 7,500 | $87K | May 27 | SEC ↗ |
Borges David J.First filing | VP, Finance & CAO | Sale | 30,000 | $382K | Jan 14 | SEC ↗ |
Borges David J.First filing | VP, Finance & CAO | Sale | 30,000 | $369K | Jan 14 | SEC ↗ |
Related companies
OMEROS CORP is in the Healthcare sector.